Left Atrial Appendage Closure
All Specialties (-)
-
WATCHMAN FLX™ Left Atrial Appendage Closure Device
WATCHMAN FLX is now FDA APPROVED for use in nonvalvular atrial fibrillation patients who are eligible for anticoagulation therapy.
Built on the most studied and implanted LAAC device in the world, WATCHMAN FLX is designed to advance procedural performance and safety while expanding the treatable patient population.- Interventional Cardiology
- Cardiac Rhythm Management
- Electrophysiology
-
WATCHMAN™ Left Atrial Appendage Closure Device
WATCHMAN
The One-Time Procedure That May Provide A Lifetime Of Stroke Risk Reduction In NVAF Patients Who Need an Alternative- Interventional Cardiology
- Cardiac Rhythm Management
- Electrophysiology